Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Biotech/Pharma Companies Look to Market for Capital

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- Over the past five months, biotech and pharma companies have increasingly turned to the stock market for much needed infusions of capital. In August, Nashville-based Cumberland Pharmaceuticals snapped a two-year industry dry spell when it conducted an initial public offering (IPO) that raised $85 million (see "Is Biotech/Pharma Beginning to Bounce Back?"). And in October, Talecris Biotherapeutics and Omeros Corp. conducted their own IPOs, raising $950 million and $68.2 million, respectively (see "Biotech/Pharma IPO Binge"). Meanwhile, Inspire Pharmaceuticals and Seattle Genetics managed to raise $115 and $136 million, respectively, in public offerings of their common stock,...

Full post as published by Patent Docs on December 30, 2009 (boomark / email).